{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T07:28:19Z","timestamp":1789198099282,"version":"build-2803163510"},"reference-count":38,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1681\/asn.2014020218","type":"journal-article","created":{"date-parts":[[2014,7,24]],"date-time":"2014-07-24T23:23:05Z","timestamp":1406244185000},"page":"192-200","source":"Crossref","is-referenced-by-count":62,"title":["Serum Fibroblast Growth Factor-23 Is Associated with Incident Kidney Disease"],"prefix":"10.1681","volume":"26","author":[{"given":"Casey M.","family":"Rebholz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgan E.","family":"Grams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josef","family":"Coresh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Selvin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lesley A.","family":"Inker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew S.","family":"Levey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul L.","family":"Kimmel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramachandran S.","family":"Vasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John H.","family":"Eckfeldt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harold I.","family":"Feldman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-yuan","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela L.","family":"Lutsey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-22-20230208","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/S0140-6736(13)60439-0","article-title":"Evolving importance of kidney disease: From subspecialty to global health burden.","volume":"382","author":"Eckardt","year":"2013","journal-title":"Lancet"},{"key":"R3-22-20230208","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1001\/jama.2010.39","article-title":"Relation between kidney function, proteinuria, and adverse outcomes.","volume":"303","author":"Hemmelgarn","year":"2010","journal-title":"JAMA"},{"key":"R4-22-20230208","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/ki.2010.483","article-title":"The definition, classification, and prognosis of chronic kidney disease: A KDIGO Controversies Conference report.","volume":"80","author":"Levey","year":"2011","journal-title":"Kidney Int"},{"key":"R5-22-20230208","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1681\/ASN.2009121293","article-title":"Forging forward with 10 burning questions on FGF23 in kidney disease.","volume":"21","author":"Wolf","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"R6-22-20230208","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/ki.2012.176","article-title":"Update on fibroblast growth factor 23 in chronic kidney disease.","volume":"82","author":"Wolf","year":"2012","journal-title":"Kidney Int"},{"key":"R7-22-20230208","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1359\/JBMR.0301264","article-title":"FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis.","volume":"19","author":"Shimada","year":"2004","journal-title":"J Bone Miner Res"},{"key":"R8-22-20230208","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1681\/ASN.2012090894","article-title":"Fractional excretion of phosphorus modifies the association between fibroblast growth factor-23 and outcomes.","volume":"24","author":"Dominguez","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"R9-22-20230208","doi-asserted-by":"crossref","first-page":"4393","DOI":"10.1172\/JCI46122","article-title":"FGF23 induces left ventricular hypertrophy.","volume":"121","author":"Faul","year":"2011","journal-title":"J Clin Invest"},{"key":"R10-22-20230208","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1056\/NEJMoa0706130","article-title":"Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis.","volume":"359","author":"Guti\u00e9rrez","year":"2008","journal-title":"N Engl J Med"},{"key":"R11-22-20230208","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1001\/jama.2011.826","article-title":"Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease.","volume":"305","author":"Isakova","year":"2011","journal-title":"JAMA"},{"key":"R12-22-20230208","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.jacc.2012.03.040","article-title":"Fibroblast growth factor-23 and death, heart failure, and cardiovascular events in community-living individuals: CHS (Cardiovascular Health Study).","volume":"60","author":"Ix","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"R13-22-20230208","doi-asserted-by":"crossref","first-page":"640","DOI":"10.7326\/0003-4819-152-10-201005180-00004","article-title":"The associations of fibroblast growth factor 23 and uncarboxylated matrix Gla protein with mortality in coronary artery disease: The Heart and Soul Study.","volume":"152","author":"Parker","year":"2010","journal-title":"Ann Intern Med"},{"key":"R14-22-20230208","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1038\/ki.2013.3","article-title":"Fibroblast growth factor 23 is not associated with and does not induce arterial calcification.","volume":"83","author":"Scialla","year":"2013","journal-title":"Kidney Int"},{"key":"R15-22-20230208","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.ahj.2011.02.012","article-title":"Plasma fibroblast growth factor 23, parathyroid hormone, phosphorus, and risk of coronary heart disease.","volume":"161","author":"Taylor","year":"2011","journal-title":"Am Heart J"},{"key":"R16-22-20230208","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1681\/ASN.2006080936","article-title":"Fibroblast growth factor 23 (FGF23) predicts progression of chronic kidney disease: The Mild to Moderate Kidney Disease (MMKD) Study.","volume":"18","author":"Fliser","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"R17-22-20230208","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1681\/ASN.2012070713","article-title":"Mineral metabolites and CKD progression in African Americans.","volume":"24","author":"Scialla","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"R18-22-20230208","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1210\/jc.2009-1603","article-title":"Circulating fibroblast growth factor 23 in patients with end-stage renal disease treated by peritoneal dialysis is intact and biologically active.","volume":"95","author":"Shimada","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"R19-22-20230208","doi-asserted-by":"crossref","first-page":"85","DOI":"10.2215\/CJN.08070811","article-title":"Serum fibroblast growth factor-23 and risk of incident chronic kidney disease in older community-dwelling women.","volume":"7","author":"Semba","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"R20-22-20230208","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1681\/ASN.2006121385","article-title":"Role of hyperphosphatemia and 1,25-dihydroxyvitamin D in vascular calcification and mortality in fibroblastic growth factor 23 null mice.","volume":"18","author":"Stubbs","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"R21-22-20230208","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/ki.1980.85","article-title":"Renal toxicity of phosphate in rats.","volume":"17","author":"Haut","year":"1980","journal-title":"Kidney Int"},{"key":"R22-22-20230208","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1111\/j.1523-1755.2004.09003.x","article-title":"The role of abnormal phosphorus metabolism in the progression of chronic kidney disease and metastatic calcification.","volume":"90","author":"Alfrey","year":"2004","journal-title":"Kidney Int Suppl"},{"key":"R23-22-20230208","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.2215\/CJN.00910113","article-title":"25 (OH) vitamin D levels and renal disease progression in patients with type 2 diabetic nephropathy and blockade of the renin-angiotensin system.","volume":"8","author":"Fern\u00e1ndez-Ju\u00e1rez","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"R24-22-20230208","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1046\/j.1523-1755.2001.00775.x","article-title":"Effects of 1,25(OH)2D3 in experimental mesangial proliferative nephritis in rats.","volume":"60","author":"Panichi","year":"2001","journal-title":"Kidney Int"},{"key":"R25-22-20230208","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1006\/jsre.2001.6221","article-title":"1,25-(OH(2))D(3) alters the transforming growth factor \u03b2 signaling pathway in renal tissue.","volume":"100","author":"Aschenbrenner","year":"2001","journal-title":"J Surg Res"},{"key":"R26-22-20230208","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1177\/039463200501800422","article-title":"Treatment with 1,25-dihydroxyvitamin D3 preserves glomerular slit diaphragm-associated protein expression in experimental glomerulonephritis.","volume":"18","author":"Migliori","year":"2005","journal-title":"Int J Immunopathol Pharmacol"},{"key":"R27-22-20230208","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1016\/S0002-9440(10)64129-6","article-title":"A vitamin D analog ameliorates glomerular injury on rat glomerulonephritis.","volume":"158","author":"Makibayashi","year":"2001","journal-title":"Am J Pathol"},{"key":"R28-22-20230208","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1111\/j.1523-1755.2005.00184.x","article-title":"Serum fibroblast growth factor-23 levels predict the future refractory hyperparathyroidism in dialysis patients.","volume":"67","author":"Nakanishi","year":"2005","journal-title":"Kidney Int"},{"key":"R29-22-20230208","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1681\/ASN.2005010052","article-title":"Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease.","volume":"16","author":"Gutierrez","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"R30-22-20230208","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1038\/ki.2011.47","article-title":"Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease.","volume":"79","author":"Isakova","year":"2011","journal-title":"Kidney Int"},{"key":"R31-22-20230208","doi-asserted-by":"crossref","first-page":"3357","DOI":"10.1210\/jc.2012-1811","article-title":"Biological variability of plasma intact and C-terminal FGF23 measurements.","volume":"97","author":"Smith","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"R32-22-20230208","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.cca.2011.02.009","article-title":"Instability of fibroblast growth factor-23 (FGF-23): Implications for clinical studies.","volume":"412","author":"Smith","year":"2011","journal-title":"Clin Chim Acta"},{"key":"R33-22-20230208","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1515\/cclm-2013-0208","article-title":"Method-specific differences in plasma fibroblast growth factor 23 measurement using four commercial ELISAs.","volume":"51","author":"Smith","year":"2013","journal-title":"Clin Chem Lab Med"},{"key":"R34-22-20230208","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1001\/jama.2011.451","article-title":"A predictive model for progression of chronic kidney disease to kidney failure.","volume":"305","author":"Tangri","year":"2011","journal-title":"JAMA"},{"key":"R36-22-20230208","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1093\/clinchem\/28.6.1379","article-title":"Dextran sulfate-Mg2+ precipitation procedure for quantitation of high-density-lipoprotein cholesterol.","volume":"28","author":"Warnick","year":"1982","journal-title":"Clin Chem"},{"key":"R37-22-20230208","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1093\/clinchem\/18.11.1419","article-title":"Simple, rapid, kinetic method for serum creatinine measurement.","volume":"18","author":"Lustgarten","year":"1972","journal-title":"Clin Chem"},{"key":"R38-22-20230208","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1056\/NEJMoa1114248","article-title":"Estimating glomerular filtration rate from serum creatinine and cystatin C.","volume":"367","author":"Inker","year":"2012","journal-title":"N Engl J Med"},{"key":"R39-22-20230208","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate.","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"key":"R42-22-20230208","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A proportional hazards model for the subdistribution of a competing risk.","volume":"94","author":"Fine","year":"1999","journal-title":"J Am Stat Assoc"}],"container-title":["Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00001751-201501000-00022","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T19:32:42Z","timestamp":1786131162000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00001751-201501000-00022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1681\/asn.2014020218","relation":{},"ISSN":["1046-6673"],"issn-type":[{"value":"1046-6673","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1]]}}}